Title : G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway.

Pub. Date : 2020 Aug

PMID : 32334286






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 G-5555 synergized miR-485-5p to alleviate cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling pathway. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
2 We evaluated the role of Pi3k/Akt signaling in regulation of miR-485-5p and cisplatin resistance with Wortmannin. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
3 Inhibition of Pi3k/Akt signaling increased miR-485-5p, thereby decreasing the cisplatin-resistance in OVCA433-CR. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
4 miR-485-5p decreased cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling, suggesting that miR-485-5p upregulation might alleviate the cisplatin resistance in ovarian patients. Cisplatin AKT serine/threonine kinase 1 Homo sapiens
5 miR-485-5p decreased cisplatin resistance in ovarian cancer cells via Pi3k/Akt signaling, suggesting that miR-485-5p upregulation might alleviate the cisplatin resistance in ovarian patients. Cisplatin AKT serine/threonine kinase 1 Homo sapiens